Search

Jaqueline S Milea

age ~53

from Irvine, CA

Get Report
Also known as:
  • Jaqueline Simon Milea
  • Jaqueline U Milea
  • Jacqueline S Milea
Related to:
Connected to:

Jaqueline Milea Phones & Addresses

  • Irvine, CA
  • 147 Kelton St #607, Allston, MA 02134
  • Boston, MA
  • Oceanside, CA

Work

  • Company:
    Allergan - Irvine, CA
    2011
  • Position:
    Manager, senior scientist, biologics stability programs

Education

  • School / High School:
    LUND UNIVERSITY, Sweden and Bucharest University
    2001
  • Specialities:
    Ph.D. in Analytical Chemistry

Skills

Biopharmaceuticals • Biotechnology • Drug Development • Cmc • Gmp • Technology Transfer • Management • Ind • Glp • Chemistry • Clinical Development • Hplc • Fda • Analytical Chemistry • Program Management • Pharmaceutical Industry • Project Management • Process Improvement • Drug Discovery • Validation • Regulatory Submissions • Quality Assurance • Vaccines • Chromatography • Process Simulation • Gcp • Lims • Product Development • Clinical Trials • Change Control • R&D • Gxp • Lifesciences • Sop • Cross Functional Team Leadership • Capa • Cell Culture • 21 Cfr Part 11 • Medical Devices • Biochemistry • Clinical Research • Oncology • Formulation • V&V • Regulatory Affairs • Cro • Pharmaceutics • Contract Manufacturing • Molecular Biology • Commercialization

Industries

Biotechnology

Resumes

Jaqueline Milea Photo 1

Associate Director, Global Cmc Ad And Qc

view source
Location:
South San Francisco, CA
Industry:
Biotechnology
Work:
Spectrum Pharmaceuticals
Associate Director, Global Cmc Ad and Qc
Halozyme Therapeutics
Associate Director, Cmc Product Development Technical Strategy
Genentech Nov 2013 - Dec 2018
Global Senior Manager, Analytical Management Technology, Product Launch and Commercials
Allergan Aug 2011 - Oct 2013
Senior Program Manager, Biopharmaceutical Development Sciences, Early and Late Phase Programs
Biogen Oct 2009 - Sep 2011
Ad Cmc Program Manager, Ad Cmc Management Small Molecule Programs
Skills:
Biopharmaceuticals
Biotechnology
Drug Development
Cmc
Gmp
Technology Transfer
Management
Ind
Glp
Chemistry
Clinical Development
Hplc
Fda
Analytical Chemistry
Program Management
Pharmaceutical Industry
Project Management
Process Improvement
Drug Discovery
Validation
Regulatory Submissions
Quality Assurance
Vaccines
Chromatography
Process Simulation
Gcp
Lims
Product Development
Clinical Trials
Change Control
R&D
Gxp
Lifesciences
Sop
Cross Functional Team Leadership
Capa
Cell Culture
21 Cfr Part 11
Medical Devices
Biochemistry
Clinical Research
Oncology
Formulation
V&V
Regulatory Affairs
Cro
Pharmaceutics
Contract Manufacturing
Molecular Biology
Commercialization
Jaqueline Milea Photo 2

Jaqueline Milea Irvine, CA

view source
Work:
ALLERGAN
Irvine, CA
2011 to Jul 2013
Manager, Senior Scientist, Biologics Stability Programs BIOGEN IDEC
Cambridge, MA
2009 to 2011
AD CMC Scientific Manager, Analytical Development CMC, Small Molecule Programs ARCHEMIX CORP
Cambridge, MA
2008 to 2009
AD/QC Manager, Pharmaceutical Development ARQULE, INC
Woburn, MA
2007 to 2008
Investigator, Pharmaceutical Development FORMATECH/WOLFE LABORATORIES, Andover
Watertown, MA
2005 to 2007
Postdoctoral Fellow, Senior Scientist BOSTON UNIVERSITY, CENTER FOR ADVANCED BIOTECHNOLOGY
Boston, MA
2002 to 2005
Department of Biomedical Engineering, Postdoctoral Researcher, Molecular Biology Research Laboratory
Education:
LUND UNIVERSITY, Sweden and Bucharest University
2001
Ph.D. in Analytical Chemistry TOR VERGATA UNIVERSITY, Italy and Bucharest University
1997
M.Sc. in Analytical Chemistry BUCHAREST UNIVERSITY
1995
B.S. in Chemistry and Physics

Us Patents

  • Liquid Bevirimat Dosage Forms For Oral Administration

    view source
  • US Patent:
    20100216751, Aug 26, 2010
  • Filed:
    Mar 25, 2010
  • Appl. No.:
    12/731786
  • Inventors:
    Jules S. Jacob - Yardley PA, US
    John Richards - Acton MA, US
    John G. Augustine - Lynn MA, US
    Jaqueline S. Milea - Boston MA, US
  • Assignee:
    Myriad Pharmaceuticals, Inc. - Salt Lake City UT
  • International Classification:
    A61K 31/56
  • US Classification:
    514169
  • Abstract:
    The present application discloses and claims liquid pharmaceutical compositions comprising bevirimat dimeglumine as a drug substance, methods of treatment comprising administering such compositions to a subject in need thereof, and the use of such compositions in the manufacture of medicaments.
Get Report for Jaqueline S Milea from Irvine, CA, age ~53
Control profile